|Expense ratio (net)||N/A|
|Last cap gain||N/A|
|Morningstar risk rating||N/A|
|Beta (3Y monthly)||N/A|
|5y average return||N/A|
|Average for category||N/A|
Bayer (BAYN.DE) was up as much as 2.2% on Tuesday a day after a federal district court judge denied the company’s motion for a new trial in the Roundup weed killer case. The case against Roundup, a product of Monsanto—now a part of Bayer—will cost the pharmaceutical company $25.3 million in total damages. This is a reduction from $80 million, of which $75 million was ordered by the jury for punitive damages.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
A San Francisco judge on Monday upheld a jury verdict that found Monsanto liable for not warning a groundskeeper that its weed killer Roundup might cause cancer, but slashed the damages award.
SAN FRANCISCO (AP) — A San Francisco jury on Friday ordered agribusiness giant Monsanto to pay $289 million to a former school groundskeeper dying of cancer, saying the company's popular Roundup weed killer contributed to his disease.